☰

Timothy P. Bender - Publications

Affiliations: 
University of Virginia, Charlottesville, VA 
Area:
Microbiology Biology
Tree Info Similar researchers PubMed Report error

52 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Upadhye A, Marshall M, Garmey JC, Bender TP, McNamara C. Retroviral Overexpression of CXCR4 on Murine B-1a Cells and Adoptive Transfer for Targeted B-1a Cell Migration to the Bone Marrow and IgM Production. Journal of Visualized Experiments : Jove. PMID 32538902 DOI: 10.3791/61003  0.444
2019 Upadhye A, Srikakulapu P, Gonen A, Hendrikx S, Perry HM, Nguyen AT, McSkimming C, Marshall M, Garmey J, Taylor A, Bender TP, Tsimikas S, Holodick NE, Rothstein TL, Witztum JL, et al. Diversification and CXCR4-Dependent Establishment of the Bone Marrow B-1a Cell Pool Governs Atheroprotective IgM Production Linked To Human Coronary Atherosclerosis. Circulation Research. PMID 31549940 DOI: 10.1161/Circresaha.119.315786  0.395
2019 Shikatani EA, Besla R, Ensan S, Upadhye A, Khyzha N, Li A, Emoto T, Chiu F, Degousee N, Moreau JM, Perry HM, Thayaparan D, Cheng HS, Pacheco S, Smyth D, ... ... Bender TP, et al. c-Myb Exacerbates Atherosclerosis through Regulation of Protective IgM-Producing Antibody-Secreting Cells. Cell Reports. 27: 2304-2312.e6. PMID 31116977 DOI: 10.1016/J.Celrep.2019.04.090  0.417
2019 Gautam S, Fioravanti J, Zhu W, Le Gall JB, Brohawn P, Lacey NE, Hu J, Hocker JD, Hawk NV, Kapoor V, Telford WG, Gurusamy D, Yu Z, Bhandoola A, Xue HH, ... ... Bender TP, et al. The transcription factor c-Myb regulates CD8 T cell stemness and antitumor immunity. Nature Immunology. 20: 337-349. PMID 30778251 DOI: 10.1038/S41590-018-0311-Z  0.436
2018 Fahl SP, Daamen AR, Crittenden RB, Bender TP. c-Myb Coordinates Survival and the Expression of Genes That Are Critical for the Pre-BCR Checkpoint. Journal of Immunology (Baltimore, Md. : 1950). PMID 29654210 DOI: 10.4049/Jimmunol.1302303  0.485
2018 Jayappa KD, Cios KJ, Gordon VL, Arora PC, Bender TP, Williams ME, Portell CA, Weber MJ. A Multi-Drug Tolerant Phenotype Is Induced By Diverse Microenvironmental Agonists in Chronic Lymphocytic Leukemia and Mantle Cell Lymphoma Blood. 132: 4120-4120. DOI: 10.1182/Blood-2018-99-119521  0.371
2018 Jayappa KD, Portell CA, Gordon VL, Narla G, Bender TP, Williams ME, Weber MJ. Drug Combinations Co-Targeting Myeloid Cell Leukemia-1 (Mcl-1) Protein Can Overcome Microenvironmentally-Induced Multi-Drug Tolerance in Non-Hodgkin Lymphomas Blood. 132: 2649-2649. DOI: 10.1182/Blood-2018-99-116759  0.361
2017 Tang F, Zhang P, Ye P, Lazarski CA, Wu Q, Bergin IL, Bender TP, Hall MN, Cui Y, Zhang L, Jiang T, Liu Y, Zheng P. A population of innate myelolymphoblastoid effector cell expanded by inactivation of mTOR complex 1 in mice. Elife. 6. PMID 29206103 DOI: 10.7554/Elife.32497  0.401
2017 Jayappa KD, Portell CA, Gordon VL, Capaldo BJ, Bekiranov S, Axelrod MJ, Brett LK, Wulfkuhle JD, Gallagher RI, Petricoin EF, Bender TP, Williams ME, Weber MJ. Microenvironmental agonists generate de novo phenotypic resistance to combined ibrutinib plus venetoclax in CLL and MCL. Blood Advances. 1: 933-946. PMID 29034364 DOI: 10.1182/Bloodadvances.2016004176  0.337
2017 Ziembik MA, Bender TP, Larner JM, Brautigan DL. Functions of protein phosphatase-6 in NF-κB signaling and in lymphocytes. Biochemical Society Transactions. 45: 693-701. PMID 28620030 DOI: 10.1042/Bst20160169  0.322
2017 Tang F, Zhang P, Ye P, Lazarski CA, Wu Q, Bergin IL, Bender TP, Hall MN, Cui Y, Zhang L, Jiang T, Liu Y, Zheng P. Author response: A population of innate myelolymphoblastoid effector cell expanded by inactivation of mTOR complex 1 in mice Elife. DOI: 10.7554/Elife.32497.055  0.304
2017 Jayappa KD, Portell CA, Gordon VL, Bender TP, Williams ME, Weber MJ. Abstract 08: Soluble agonists in the in vivo macroenvironment generate phenotypic de novo resistance to BTK/Bcl-2 targeted therapies in diverse B-cell malignancies Clinical Cancer Research. 23: 8-8. DOI: 10.1158/1557-3265.Hemmal17-08  0.355
2016 Jayappa KD, Portell CA, Gordon VL, Capaldo BJ, Bekiranov S, Wulfkuhle JD, Gallagher RI, Petricoin EF, Bender TP, Williams ME, Weber MJ. Extrinsic Factors in the In Vivo Macroenvironment Generate Phenotypic Resistance to BTK/Bcl-2 Targeted Therapies in Chronic Lymphocytic Leukemia and Mantle Cell Lymphoma Blood. 128: 754-754. DOI: 10.1182/Blood.V128.22.754.754  0.332
2015 Rosenfeld SM, Perry HM, Gonen A, Prohaska TA, Srikakulapu P, Grewal S, Das D, McSkimming C, Taylor AM, Tsimikas S, Bender TP, Witztum JL, McNamara CA. B-1b Cells Secrete Atheroprotective IgM and Attenuate Atherosclerosis. Circulation Research. 117: e28-39. PMID 26082558 DOI: 10.1161/Circresaha.117.306044  0.392
2015 Jayappa KD, Portell CA, Gordon V, Williams ME, Petricoin EF, Bender TP, Weber MJ. Ligands That Mimic the Tissue Microenvironment of Replicating Chronic Lymphocytic Leukemia (CLL) and Mantle Cell Lymphoma (MCL) Protect Ex Vivo Patient Cell Samples from the Cytotoxicity of Combined Treatment with Ibrutinib and Venetoclax (ABT-199) Blood. 126: 448-448. DOI: 10.1182/Blood.V126.23.448.448  0.396
2013 Perry HM, Oldham SN, Fahl SP, Que X, Gonen A, Harmon DB, Tsimikas S, Witztum JL, Bender TP, McNamara CA. Helix-loop-helix factor inhibitor of differentiation 3 regulates interleukin-5 expression and B-1a B cell proliferation. Arteriosclerosis, Thrombosis, and Vascular Biology. 33: 2771-9. PMID 24115031 DOI: 10.1161/Atvbaha.113.302571  0.413
2012 Perry HM, Bender TP, McNamara CA. B cell subsets in atherosclerosis. Frontiers in Immunology. 3: 373. PMID 23248624 DOI: 10.3389/Fimmu.2012.00373  0.403
2012 Tewalt EF, Cohen JN, Rouhani SJ, Guidi CJ, Qiao H, Fahl SP, Conaway MR, Bender TP, Tung KS, Vella AT, Adler AJ, Chen L, Engelhard VH. Lymphatic endothelial cells induce tolerance via PD-L1 and lack of costimulation leading to high-level PD-1 expression on CD8 T cells. Blood. 120: 4772-82. PMID 22993390 DOI: 10.1182/Blood-2012-04-427013  0.414
2012 Doran AC, Lipinski MJ, Oldham SN, Garmey JC, Campbell KA, Skaflen MD, Cutchins A, Lee DJ, Glover DK, Kelly KA, Galkina EV, Ley K, Witztum JL, Tsimikas S, Bender TP, et al. B-cell aortic homing and atheroprotection depend on Id3. Circulation Research. 110: e1-12. PMID 22034493 DOI: 10.1161/Circresaha.111.256438  0.381
2012 Waldron T, De Dominici M, Soliera AR, Audia A, Iacobucci I, Lonetti A, Martinelli G, Zhang Y, Martinez R, Hyslop T, Bender TP, Calabretta B. c-Myb and its target Bmi1 are required for p190BCR/ABL leukemogenesis in mouse and human cells. Leukemia. 26: 644-53. PMID 21960247 DOI: 10.1038/Leu.2011.264  0.336
2011 Bezman NA, Chakraborty T, Bender T, Lanier LL. miR-150 regulates the development of NK and iNKT cells. The Journal of Experimental Medicine. 208: 2717-31. PMID 22124110 DOI: 10.1084/Jem.20111386  0.338
2011 Matalová E, Buchtová M, Tucker AS, Bender TP, Jane?ková E, Lungová V, Balková S, Smarda J. Expression and characterization of c-Myb in prenatal odontogenesis. Development, Growth & Differentiation. 53: 793-803. PMID 21762405 DOI: 10.1111/J.1440-169X.2011.01287.X  0.401
2011 Gimferrer I, Hu T, Simmons A, Wang C, Souabni A, Busslinger M, Bender TP, Hernandez-Hoyos G, Alberola-Ila J. Regulation of GATA-3 expression during CD4 lineage differentiation. Journal of Immunology (Baltimore, Md. : 1950). 186: 3892-8. PMID 21357543 DOI: 10.4049/Jimmunol.1003505  0.421
2010 Bender TP. A new window on c-Myb function. Blood. 116: 1190-1. PMID 20798239 DOI: 10.1182/Blood-2010-06-287300  0.417
2010 Hu T, Simmons A, Yuan J, Bender TP, Alberola-Ila J. The transcription factor c-Myb primes CD4+CD8+ immature thymocytes for selection into the iNKT lineage. Nature Immunology. 11: 435-41. PMID 20383148 DOI: 10.1038/Ni.1865  0.595
2010 Yuan J, Crittenden RB, Bender TP. c-Myb promotes the survival of CD4+CD8+ double-positive thymocytes through upregulation of Bcl-xL. Journal of Immunology (Baltimore, Md. : 1950). 184: 2793-804. PMID 20142358 DOI: 10.4049/Jimmunol.0902846  0.639
2010 Trampont PC, Tosello-Trampont AC, Shen Y, Duley AK, Sutherland AE, Bender TP, Littman DR, Ravichandran KS. CXCR4 acts as a costimulator during thymic beta-selection. Nature Immunology. 11: 162-70. PMID 20010845 DOI: 10.1038/Ni.1830  0.632
2010 Waldron TJ, Soliera AR, Zhang Y, Martinez R, Hyslop T, Bender T, Calabretta B. Abstract 5061: Induction of B cell acute lymphoblastic leukemia by BCR/ABL requires c-Myb and its activation of Bmi-1 Cancer Research. 70: 5061-5061. DOI: 10.1158/1538-7445.Am10-5061  0.405
2009 Smith E, von Vietinghoff S, Stark MA, Zarbock A, Sanders JM, Duley A, Rivera-Nieves J, Bender TP, Ley K. T-lineage cells require the thymus but not VDJ recombination to produce IL-17A and regulate granulopoiesis in vivo. Journal of Immunology (Baltimore, Md. : 1950). 183: 5685-93. PMID 19843951 DOI: 10.4049/Jimmunol.0900887  0.631
2009 Fahl SP, Crittenden RB, Allman D, Bender TP. c-Myb is required for pro-B cell differentiation. Journal of Immunology (Baltimore, Md. : 1950). 183: 5582-92. PMID 19843942 DOI: 10.4049/Jimmunol.0901187  0.476
2009 Giles AJ, Bender TP, Ravichandran KS. The adaptor protein Shc plays a key role during early B cell development. Journal of Immunology (Baltimore, Md. : 1950). 183: 5468-76. PMID 19828641 DOI: 10.4049/Jimmunol.0902344  0.433
2008 Lidonnici MR, Corradini F, Waldron T, Bender TP, Calabretta B. Requirement of c-Myb for p210 BCR/ABL-dependent transformation of hematopoietic progenitors and leukemogenesis Blood. 111: 4771-4779. PMID 18227349 DOI: 10.1182/Blood-2007-08-105072  0.386
2006 Chen J, Kremer CS, Bender TP. The carbonic anhydrase I locus contains a c-Myb target promoter and modulates differentiation of murine erythroleukemia cells. Oncogene. 25: 2758-72. PMID 16407849 DOI: 10.1038/Sj.Onc.1209295  0.402
2005 Thomas MD, Kremer CS, Ravichandran KS, Rajewsky K, Bender TP. c-Myb is critical for B cell development and maintenance of follicular B cells. Immunity. 23: 275-86. PMID 16169500 DOI: 10.1016/J.Immuni.2005.08.005  0.614
2004 Bender TP, Kremer CS, Kraus M, Buch T, Rajewsky K. Critical functions for c-Myb at three checkpoints during thymocyte development Nature Immunology. 5: 721-729. PMID 15195090 DOI: 10.1038/Ni1085  0.453
2002 Zhang L, Camerini V, Bender TP, Ravichandran KS. A nonredundant role for the adapter protein Shc in thymic T cell development. Nature Immunology. 3: 749-55. PMID 12101399 DOI: 10.1038/Ni820  0.443
2002 Chen J, Kremer CS, Bender TP. A Myb dependent pathway maintains Friend murine erythroleukemia cells in an immature and proliferating state. Oncogene. 21: 1859-69. PMID 11896618 DOI: 10.1038/Sj.Onc.1205003  0.416
2002 Kulkarni MS, Daggett JL, Bender TP, Kuehl WM, Bergsagel PL, Williams ME. Frequent inactivation of the cyclin-dependent kinase inhibitor p18 by homozygous deletion in multiple myeloma cell lines: ectopic p18 expression inhibits growth and induces apoptosis. Leukemia. 16: 127-34. PMID 11840272 DOI: 10.1038/Sj.Leu.2402328  0.306
2001 Chen J, Bender TP. A novel system to identify Myb target promoters in friend murine erythroleukemia cells. Blood Cells, Molecules & Diseases. 27: 429-36. PMID 11500057 DOI: 10.1006/Bcmd.2001.0401  0.421
1999 Allen RD, Bender TP, Siu G. c-Myb is essential for early T cell development. Genes & Development. 13: 1073-8. PMID 10323859 DOI: 10.1101/Gad.13.9.1073  0.427
1999 Müller C, Yang R, Idos G, Tidow N, Diederichs S, Koch OM, Verbeek W, Bender TP, Koeffler HP. c-myb Transactivates the Human Cyclin A1 Promoter and Induces Cyclin A1 Gene Expression Blood. 94: 4255-4262. DOI: 10.1182/Blood.V94.12.4255.424K32_4255_4262  0.397
1998 Jeng MH, Shupnik MA, Bender TP, Westin EH, Bandyopadhyay D, Kumar R, Masamura S, Santen RJ. Estrogen receptor expression and function in long-term estrogen-deprived human breast cancer cells. Endocrinology. 139: 4164-74. PMID 9751496 DOI: 10.1210/Endo.139.10.6229  0.351
1996 Miglarese MR, Richardson AF, Aziz N, Bender TP. Differential regulation of c-Myb-induced transcription activation by a phosphorylation site in the negative regulatory domain. The Journal of Biological Chemistry. 271: 22697-705. PMID 8798443 DOI: 10.1074/Jbc.271.37.22697  0.342
1995 Toth CR, Hostutler RF, Baldwin AS, Bender TP. Members of the nuclear factor kappa B family transactivate the murine c-myb gene. The Journal of Biological Chemistry. 270: 7661-71. PMID 7706314 DOI: 10.1074/Jbc.270.13.7661  0.382
1995 Aziz N, Miglarese MR, Hendrickson RC, Shabanowitz J, Sturgill TW, Hunt DF, Bender TP. Modulation of c-Myb-induced transcription activation by a phosphorylation site near the negative regulatory domain. Proceedings of the National Academy of Sciences of the United States of America. 92: 6429-33. PMID 7604007 DOI: 10.1073/Pnas.92.14.6429  0.326
1993 Cuddihy AE, Brents LA, Aziz N, Bender TP, Kuehl WM. Only the DNA binding and transactivation domains of c-Myb are required to block terminal differentiation of murine erythroleukemia cells. Molecular and Cellular Biology. 13: 3505-13. PMID 8497265 DOI: 10.1128/mcb.13.6.3505-3513.1993  0.364
1991 Isakson PC, Purkerson J, Catron K, Bender TP. A novel method for synchronizing a B cell lymphoma. Journal of Immunological Methods. 145: 137-42. PMID 1765644 DOI: 10.1016/0022-1759(91)90319-B  0.406
1990 McClinton D, Stafford J, Brents L, Bender TP, Kuehl WM. Differentiation of mouse erythroleukemia cells is blocked by late up-regulation of a c-myb transgene. Molecular and Cellular Biology. 10: 705-10. PMID 2405253 DOI: 10.1128/mcb.10.2.705-710.1990  0.387
1990 Catron KM, Toth CR, Purkerson J, Isakson P, Bender TP. Constitutive and cell cycle regulated expression of c-myc mRNA is related to the state of differentiation in murine B-lymphoid tumors. Current Topics in Microbiology and Immunology. 166: 197-202. PMID 2073799 DOI: 10.1007/978-3-642-75889-8_25  0.416
1988 Kuehl WM, Bender TP, Stafford J, McClinton D, Segal S, Dmitrovsky E. Expression and function of the c-myb oncogene during hematopoietic differentiation. Current Topics in Microbiology and Immunology. 141: 318-23. PMID 3063446 DOI: 10.1007/978-3-642-74006-0_42  0.346
1988 Bender TP, Catron KM, Kuehl WM, Thompson CB. Sense and anti-sense transcription in the murine c-myb attenuator region. Current Topics in Microbiology and Immunology. 141: 324-9. PMID 2463898 DOI: 10.1007/978-3-642-74006-0_43  0.448
1987 Bender TP, Thompson CB, Kuehl WM. Differential expression of c-myb mRNA in murine B lymphomas by a block to transcription elongation. Science (New York, N.Y.). 237: 1473-6. PMID 3498214 DOI: 10.1126/Science.3498214  0.414
Show low-probability matches.